Fresenius - the health care group
The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed.
Moody’s Investors Service has upgraded the corporate credit rating of Fresenius from Ba1 to Baa3 with a stable outlook.>>>
Ulf Mark Schneider, CEO of Fresenius, said: “Our strong growth trend continued with double-digit constant currency sales and earnings growth in the first nine months. All business segments contributed to the excellent financial results. (...)”>>>
Rice Powell, chief executive officer of Fresenius Medical Care stated: “With the dynamic growth in our Care Coordination business and our continued strong operating performance in our core businesses, we are well positioned for future success. We are very satisfied with our accomplishments in the third quarter despite the unfavorable currency impacts. [...]"
Fresenius successfully placed US$300 million of senior unsecured notes with a maturity of 7 years. >>>
Fresenius intends to issue US$300 million of senior unsecured notes with a maturity of 7 years. The proceeds of this offering will be used to refinance short-term debt, extending our maturity profile. >>>